Litican 50 mg/2 ml inj. sol. i.m./i.v. amp. 6 x 2 ml
Active ingredient: Alizapride
View notice details →News topic
Notice identifier: BE122823
All current shortage notices related to Notice identifier: BE122823, structured by product, country, active ingredient and reporting period.
2 noticesLitican 50 mg/2 ml inj. sol. i.m./i.v. amp. 6 x 2 ml
Active ingredient: Alizapride
View notice details →Plan supply. Connect sourcing and warehousing.
For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.
Improve sourcing and supply availability
Researching this shortage professionally? We assess sourcing routes, suppliers and cross-border supply against your requirements. A notice does not confirm stock availability.
Send a sourcing enquiry →Pharma warehouse and pharmaceutical warehousing in Cheb
Medicine storage, batch and expiry control, picking and distribution for Germany and Europe. We agree the storage profile, temperature and capacity with you.
Request warehouse capacity →